hottod
5,134 Posts.
10,305
Date:
08/12/21
Time:
12:12:58
Post #:
58156409
The two doses exhibit minor differences in delivery profile, with mean peak plasma concentrations for the 75 mg dose appearing 2 hours after dosing, whereas peak plasma concentrations for the 150 mg dose were evident three hours after dosing. The absorption period of the 150 mg dose was also longer, with CBD detected in the blood one week after dosing.
“The results are exciting and show that the delivery profiles from both doses could support utility across a range of potential indications, whether they require once per day, or twice per day, dosing.”
Considering that
I can certainly see utility for TPM in a CBD formulation for the treatment of anxiety.
- between 1 in 4 and 1 in 5 adults in both Australia the US suffer from anxiety *^
- multiple studies indicate that CBD is helpful in treating anxiety#
- TPM formulation with CBD demonstrated a nice, steady, long-acting delivery profile
right on ht
- Forums
- ASX - By Stock
- Ann: Avecho receives ethics approval for Phase III CBD trial
hottod 5,134 Posts. 10,305 Date: 08/12/21 Time: 12:12:58 Post #:...
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $1.801K | 512.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 94441246 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 20308827 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 94441246 | 0.003 |
21 | 67185176 | 0.002 |
10 | 14500009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 20308827 | 11 |
0.005 | 56913059 | 27 |
0.006 | 23195872 | 17 |
0.007 | 15212721 | 9 |
0.008 | 5858888 | 5 |
Last trade - 15.46pm 06/05/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online